ArticleCancer immunology, immunotherapy : CII2022

Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.

E Gefard-Gontier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.